Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.

MLA

Dolan, M.Eileen, et al. “Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 23, no. 19, Oct. 2017, pp. 5757–68. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-16-3224.

APA

Dolan, M. E., El Charif, O., Wheeler, H. E., Gamazon, E. R., Ardeshir-Rouhani-Fard, S., Monahan, P., Feldman, D. R., Hamilton, R. J., Vaughn, D. J., Beard, C. J., Fung, C., Kim, J., Fossa, S. D., Hertz, D. L., Mushiroda, T., Kubo, M., Einhorn, L. H., Cox, N. J., & Travis, L. B. (2017). Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(19), 5757–5768. https://doi.org/10.1158/1078-0432.CCR-16-3224

Chicago

Dolan, M Eileen, Omar El Charif, Heather E Wheeler, Eric R Gamazon, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, Darren R Feldman, et al. 2017. “Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 23 (19): 5757–68. doi:10.1158/1078-0432.CCR-16-3224.